Amneal Pharmaceuticals (AMRX) Treasury Shares (2018 - 2025)

Amneal Pharmaceuticals' Treasury Shares history runs 7 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• In Q4 2025, Treasury Shares fell 87.36% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (down 87.36% YoY), while the FY2025 annual figure was $2.2 million, down 87.36% from the prior year.
• Treasury Shares was $2.2 million for Q4 2025 at Amneal Pharmaceuticals, down from $17.6 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $17.9 million in Q4 2022 to a low of $2.2 million in Q4 2025.
• Historically, Treasury Shares has averaged $13.8 million across 4 years, with a median of $17.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares gained 0.7% in 2024, then sank 87.36% in 2025.
• A 4-year view of Treasury Shares shows it stood at $17.9 million in 2022, then dropped by 2.64% to $17.5 million in 2023, then increased by 0.7% to $17.6 million in 2024, then tumbled by 87.36% to $2.2 million in 2025.
• The last three Treasury Shares figures came in at $2.2 million (Q4 2025), $17.6 million (Q4 2024), and $17.5 million (Q4 2023), per Business Quant data.